| P50 | author | Vic Hasselblad | Q63101608 |
| | James Douketis | Q100404477 |
| P2093 | author name string | Sam Schulman | |
| | Thomas L Ortel | |
| | Nathan P Clark | |
| | BRIDGE Investigators | |
| | Andrei L Kindzelski | |
| P2860 | cites work | Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632902 |
| | Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis | Q28174135 |
| | A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey | Q34105149 |
| | A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study | Q34200483 |
| | Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q34252907 |
| | Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o | Q34388837 |
| | Aspirin in patients undergoing noncardiac surgery | Q34412633 |
| | Relaxing the rule of ten events per variable in logistic and Cox regression | Q34593498 |
| | Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures | Q34683960 |
| | Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752584 |
| | The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation | Q36350019 |
| | Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation | Q37062044 |
| | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. | Q37624933 |
| | Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial | Q38469560 |
| | Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry | Q43244935 |
| | Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). | Q43840992 |
| | Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question | Q46557273 |
| | Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. | Q50944058 |
| | Predictors of major bleeding in peri-procedural anticoagulation management | Q57907851 |
| | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial | Q57943255 |
| | Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes | Q81636065 |
| | The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER) | Q83994919 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | (RS)-warfarin | Q407431 |
| P304 | page(s) | 108-114 | |
| P577 | publication date | 2017-09-21 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial | |
| P478 | volume | 195 | |